Endurance Wealth Management, Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

Endurance Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$0.92 - $1.22 $6,210 - $8,235	-6,750 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$0.67 - $1.51 $4,522 - $10,192	6,750 New	6,750 $9,000
Q1 2021 May 05, 2021	SELL	$0.96 - $1.74 $12,720 - $23,055	-13,250 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$0.67 - $0.96 $8,040 - $11,520	12,000 Added 960.0%	13,250 $10,000
Q4 2019 Jan 14, 2020	BUY	$0.63 - $2.27 $787 - $2,837	1,250 New	1,250 $2,000

3.56M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $134M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.